Eledon Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Eledon Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate from Q1 2019 to Q2 2024.
  • Eledon Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending June 30, 2024 was $197K.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $197K Jun 30, 2024 10-Q 2024-08-19
Q4 2022 $388K +$176K +83% Dec 31, 2022 10-K 2023-03-30
Q3 2022 $389K Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $200K Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $200K Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $212K Dec 31, 2021 10-K 2022-03-24
Q1 2020 $146K -$42K -22.3% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $146K Dec 31, 2019 10-K 2020-03-17
Q3 2019 $188K Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $188K Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $188K Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.